YD BioYDES
13F holders, Q4 2025 (December 31)10holders
4new positions
4sold out
1famous investor
$12.19avg. 13F price*
At the end of Q4 2025, 10 institutions reported holding YD Bio Ltd. (YDES) in their 13F filings, unchanged from Q3 2025. 4 opened new positions and 4 sold out. The largest holders were Geode Capital Management, LLC ($711K), Cerity Partners LLC ($395K) and Cypress Capital Management LLC (WY) ($336K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- YD Bio Ltd.
- CUSIP
- G98301107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $192K |
| Exits | 4 | $768K |
All 13F filers, Q3 2025 → Q4 2025: 21,071 shares bought and 54,999 shares sold, net −33,928 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Geode Capital Management, LLC | 0.00% | Add +10.0% | 58,363 | $711K |
| Cerity Partners LLC | 0.00% | No change | 32,406 | $395K |
| Cypress Capital Management LLC (WY) | 0.33% | Reduce -8.2% | 27,540 | $336K |
| Citadel Advisors | 0.00% | New | 11,549 | $141K |
| UBS Group AG | 0.00% | Reduce -30.3% | 7,192 | $88K |
| Wolverine Asset Management LLC | 0.00% | New | 2,516 | $31K |
| Citigroup Inc. | 0.00% | New | 1,709 | $21K |
| Morgan Stanley | 0.00% | Reduce -97.1% | 299 | $4K |
| Bank of America Corp. | 0.00% | New | 5 | $61 |
| FMR LLC | 0.00% | No change | 1 | $12 |
"% of holder's portfolio" is YDES's weight in each manager's 13F, not the share of YD Bio Ltd. the manager owns.